gerd and semaglutide Risk of Barrett's Esophagus New Study finds that Patients with Type 2 Diabetes who take GLP-1 receptor agonist (RA) like Ozempic and Wegovy experience much more Gastroesophageal Reflux Disease (GERD) GLP-1 Heartburn: Acid Reflux Management

Context for confounding and differential diagnosis: SGLT2 inhibitors are known to increase genital mycotic infection risk, including vulvovaginal candidiasis, and real-world studies demonstrate clinically significant vaginitis incidence in usersmaking SGLT2 exposure a critical confounder when patients attribute yeast infections to semaglutide

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

Diabetes Obes Metab 24(9):17881799

Research has demonstrated significant interest in combining Cagrilintide with GLP-1 agents to explore synergistic effects on metabolic and satiety pathways

Health coaching is currently paused